RhumbLine Advisers’s Kazia Therapeutics KZIA Stock Holding History
Bought
Maintained
Sold
Other funds holding KZIA
DIG
RhumbLine Advisers's KZIA Position: Q3 2026 in Review
RhumbLine Advisers reduced its Kazia Therapeutics (KZIA) stake by 16% in Q3 2026, selling an estimated $2.67K and leaving 1,083 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3831.
RhumbLine Advisers first reported a position in KZIA in Q2 2023 and has held it in 14 quarters since. The position peaked at $18.2K in Q2 2026. 55 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.
- RhumbLine Advisers held 1,083 shares of Kazia Therapeutics worth $10.4K as of Q3 2026.
- RhumbLine Advisers sold 213 Kazia Therapeutics shares in Q3 2026, an estimated $2.67K.
- Kazia Therapeutics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3831 holding.
- RhumbLine Advisers first reported a position in Kazia Therapeutics in Q2 2023 and has held it in 14 quarters since.
- RhumbLine Advisers's Kazia Therapeutics position peaked at $18.2K in Q2 2026.
- 55 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.